Brief: Alkem Laboratories March-Quarter Consol Net Profit Falls
May 19 (Reuters) - Alkem Laboratories Ltd ALKE.NS :
* MARCH-QUARTER CONSOL NET PROFIT 709.8 MILLION RUPEES VERSUS 1.08 BILLION
RUPEES
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 29.03 BILLION RUPEES VERSUS
24.84
BILLION RUPEES
* FINAL DIVIDEND OF 10 RUPEES PER SHARE
Source text for Eikon: ID:
Further company coverage: ALKE.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees